Allergy/Asthma News

A strong association was observed between asthma and anti-citrullinated antibody elevation in a cohort of women with rheumatoid arthritis, and this association was independent of smoking, according to recent findings.

A need exists for treatments for specific eosinophilic granulomatosis with polyangiitis and medications to control symptoms and improve outcomes in patients with asthma, according to findings published in the Journal of Clinical Rheumatology.

Although there have been improvements over the years, racial, socioeconomic and ethnic disparities in food allergy are still prevalent in the United States, according to a presentation at the American College of Asthma, Allergy & Immunology Scientific Meeting.

HOUSTON — Kids prefer a patch to oral treatment for peanut allergy, according to study results presented at American College of Asthma, Allergy & Immunology Scientific Meeting.

HOUSTON — ProAir Digihaler, a multidose dry powder inhaler with built-in sensors that record information about its use and measure inspiratory flow, could dramatically change the course of asthma treatment, according to a presenter at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting.

HOUSTON — New data from Russia indicate that patients with bronchial asthma experienced significant improvement in clinical symptoms and lung function parameters after treatment with inhaled synthetic lung surfactant in addition to inhaled corticosteroids.

HOUSTON — Forced exhaled nitric oxide, or FeNO, may be useful for diagnosing cough variant asthma in patients with chronic cough who have normal spirometry, researchers reported at the American College of Allergy, Asthma and Immunology Annual Meeting.

HOUSTON — Among inner-city children, poor visual recognition of asthma controller medications by patients and their caregivers is linked to worse compliance and disease outcomes, according to new data.

HOUSTON — Although most patients with allergy are receptive to the idea of telemedicine, some allergy practitioners are not, according to several presentations at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting.

HOUSTON — Not all children and teenagers will embrace maintenance food allergy treatments, such as the Viaskin Peanut epicutaneous patch or the biologic oral immunotherapy for peanut allergy known as AR101 — both of which are investigational therapies — according to a speaker at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting.